PTAB/USPTO Update - October 2023

PTAB/USPTO Update - October 2023

Client Alert

Authors

USPTO News

Notices, Guidance, and Requests

Final Rules

  • There are no new final rules.

Interim Rules

  • There are no new interim rules.

Proposed Rules

  • There are no new proposed rules

Proposed Legislation

  • Medication Affordability and Patent Integrity Act (bill introduced by Representatives Ann M. Kuster, Diana Harshbarger on September 13, 2023 “[t]o require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office.”)

  • Prohibiting Adversarial Patents Act of 2023 (bill introduced on September 14, 2023 “[t]o amend title 35, United State Code, to require the Director of the United States Patent and Trademark Office to require disclosures in patent applications regarding ties to the People’s Republic of China and other foreign adversaries, and for other purposes.”)

PTAB Decisions

  • New Precedential PTAB Decisions 

    • There are no new informative PTAB decisions.

  • New Informative PTAB Decisions 

    • There are no new informative PTAB decisions.

  • Director Review Decisions 

    • There are no new director review decisions.

Authors

More From This Series

Notice

We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.